Interaction-Aware Clustering of Molecular Statuses for Disease Progression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for analyzing genetic disease progression, such as cancer, are inefficient due to the complexity of molecular pathways and the vast amount of experimental data generated, which hinders the ability to simulate disease progression accurately and personalize therapies.
Innovation Solution
A computer-implemented method and system that uses a dynamic prediction model to analyze molecular interactions over time, clustering molecular statuses with an interaction-aware metric to efficiently analyze genetic disease progression, allowing for personalized therapy determination and disease sub-type identification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional methods are used to analyze genetic disease progression, then comprehensive data collection is possible, but analysis efficiency is low and extensive experiments are required
Solution Approach 1:
The patent applies preliminary action by pre-computing and storing interaction metrics between molecular statuses before actual disease progression analysis. The system calculates interaction-aware metrics (such as cosine similarity, Jaccard index, or custom biological interaction scores) between all pairs of molecular statuses in advance, stores them in a metric matrix, and reuses these pre-computed values during clustering operations. This eliminates the need to re-calculate interaction complexities during each analysis run, dramatically reducing experimental time and computational overhead while maintaining comprehensive data analysis capability
Solution Approach 2:
The patent uses copying by creating simplified representations of complex molecular interaction data through clustering. Instead of analyzing every individual molecular status separately, the system generates cluster prototypes that represent groups of similar molecular statuses. These cluster prototypes serve as compressed copies that capture the essential characteristics of large groups of molecular states, enabling efficient disease progression analysis without requiring exhaustive examination of all original data points
2Reliability
If molecular statuses are clustered using traditional metrics, then computation is simpler, but the analysis does not account for molecular interactions
Solution Approach 1:
The patent introduces an intermediary element - the interaction-aware metric matrix - that mediates between simple distance-based clustering algorithms and complex molecular interaction data. Instead of directly comparing raw molecular statuses which would require complex interaction modeling, the system uses pre-computed interaction metrics as an intermediary representation. This metric matrix serves as a bridge that encapsulates complex biological interaction knowledge in a computationally tractable form, allowing standard clustering algorithms to produce biologically meaningful results without directly handling the full complexity of molecular interactions
Solution Approach 2:
The patent applies parameter changes by transforming the clustering problem from using simple distance metrics to using interaction-aware metrics. The system modifies the distance parameter in clustering algorithms by replacing Euclidean or Manhattan distance with interaction-aware measures such as cosine similarity weighted by interaction strength, or Jaccard index adjusted for biological pathway relationships. This parameter transformation maintains compatibility with existing clustering frameworks while incorporating complex interaction information, resolving the contradiction between analytical accuracy and computational complexity
3Loss of information
If comprehensive molecular data is collected, then complete disease understanding is achieved, but data complexity hinders accurate simulation
Solution Approach 1:
The patent applies the extraction principle by selectively extracting and emphasizing interaction information between molecular statuses while filtering out redundant or less relevant data. The system computes interaction-aware metrics that specifically capture meaningful biological relationships (such as pathway co-membership, protein-protein interactions, or gene regulatory relationships) and uses these extracted interaction patterns as the basis for clustering. This extraction approach maintains complete molecular information while reducing complexity by focusing computational effort on the most biologically significant interaction patterns rather than treating all molecular data equally
Data Source
AI summary
Analysis of genetic disease progression may be provided. Data about a set of molecular status may be received. A dynamic prediction model of molecular interactions may be provided over time. The molecular statuses of the set over time may be determined using the dynamic prediction model. The determined molecular statuses may be clustered by applying an interaction-aware metric for the analysis of the genetic disease progression.